about
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansCannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory.The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disordersTreatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteersPreliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteersDelay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys.Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use DisorderEndocannabinoid metabolism in the prefrontal cortex in schizophrenia.Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudyDoxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.Inpatient detoxification from a synthetic cannabinoid and control of postdetoxification cravings with naltrexone.Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms.Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat.Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention.Primate trace amine receptor 1 modulation by the dopamine transporter."Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents.A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders.Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brainNicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterizationRecovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeysPsychosis and synthetic cannabinoidsFAAH variant Pro129Thr modulates subjective effects produced by cocaine administrationThe prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorderRivastigmine does not alter cocaine-induced subjective effects or self-administrationUse of Guanfacine for Cannabis Use Disorder and Related Symptomology
P50
Q28265851-6C1CDE4C-AF34-414C-99BC-8C36022DE3CFQ30497212-CDD76966-DE0C-423C-A1A0-E9A5833C0AFBQ33576326-F9761084-F3AD-4741-B895-306B2E445EEAQ33993479-C06F4BBF-7750-4F8A-9C56-F53A1586FCE3Q33998159-D6F929FE-063F-487C-AE13-872D0F3CC5E5Q35576598-7E49E945-627B-4BB4-B074-A312D601DC97Q35580343-B27F0C57-FF56-452F-A1C3-83AB1F797CDBQ35609711-7B25C758-D117-473E-9953-43840FFAD017Q35892708-AFC5BDA8-53AE-4C66-8EEF-507012DA3A0CQ36749831-A75E38CB-D8F1-4D11-B550-AE87BCC2A63BQ36831875-4EC2BD2D-F850-4C2F-BBA0-94BBB29108C8Q37137803-FEF43EC9-F271-4B2D-89D0-A36A02BD0B7AQ38391832-BE7541B8-1A86-4FE4-9CE4-A7A5EF5AA54BQ38428409-CD3E2534-66CF-4C86-90C1-69BDAD56C50CQ40007746-3371E9FC-491F-4BCB-A411-5D2A1B94A9DDQ40362823-9D49AE1B-CF28-4C3E-B7F1-8E907265BB45Q43134408-B55FC77B-3013-4297-949C-53D61ED320FEQ44239962-A040338D-B2EC-47E4-A834-1420767CE025Q44332084-A660D829-1E97-4DDC-A186-9EC0CE439401Q44398446-AB060594-2913-48AC-A7C5-17CF14C0975BQ44413284-DB903213-2A9C-47DB-8AAD-14D14F470263Q44705377-CFC76BC2-5FD5-4C37-9771-DA58AB11B08CQ46375413-895928B6-E8FA-4760-BD1D-8497F06349E6Q47913202-FC569841-8C71-4A67-8570-1CA7E797C8FEQ48169882-96FB7BB3-9A10-4440-81C1-AEE817588011Q48308137-A5CFE03C-D843-47CC-B807-209FE9F9141FQ48364989-3D06C8F2-DF0D-499F-9173-8C97981E6E7AQ50578196-8BDC0209-F3C8-4469-BAC7-36A78B7F9CCAQ71061185-A411F6C5-4B95-43BA-AC58-3A24B741A8DBQ74326632-1D7EBAA6-1862-47FE-B8B8-F733473CB26FQ90765557-52C9370F-75F3-4DDE-B464-9524C3B95FA1Q91041715-F6C7E60D-D305-4DB6-820C-D67962BAB5D4Q91042231-3F1C2988-A261-4CBF-B73B-CF73B61F4D88Q91936522-ECFD0609-FB0E-4BE7-8D09-66DB938A3F49Q92728099-D266D97E-8200-4449-B6F0-39D642F37718Q93097769-2927ED5B-451A-4F71-BE1F-C7690BDB8B2E
P50
description
researcher ORCID ID = 0000-0002-8272-0778
@en
name
Christopher D Verrico
@ast
Christopher D Verrico
@en
Christopher D Verrico
@nl
type
label
Christopher D Verrico
@ast
Christopher D Verrico
@en
Christopher D Verrico
@nl
prefLabel
Christopher D Verrico
@ast
Christopher D Verrico
@en
Christopher D Verrico
@nl
P31
P496
0000-0002-8272-0778